logo

GDRX

Goodrx·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

GDRX fundamentals

Goodrx (GDRX) released its earnings on Nov 4, 2025: revenue was 196.00M (YoY +0.38%), beat estimates; EPS was 0.08 (YoY 0.00%), missed estimates.
Revenue / YoY
196.00M
+0.38%
EPS / YoY
0.08
0.00%
Report date
Nov 4, 2025
GDRX Earnings Call Summary for Q3,2025
  • Manufacturer Solutions Dominance: 35% YoY growth, 200+ brand programs, and direct-to-consumer partnerships.
  • PBM Shift: Payers adopting point-of-sale discounts, aligning with GoodRx's cash price model.
  • TrumpRx Opportunity: 2026 integration with HHS to link lowest-cost prescriptions to GoodRx.
  • 2026 Growth Drivers: HCP engagement, e-commerce, and employer carve-out programs.
  • Financial Resilience: $66.3M EBITDA, 33.8% margin, and $273.5M cash on hand.
EPS
Revenue

Revenue & Expenses

GDRX has released its 2025 Q3 earnings report, with revenue of 196.03M, reflecting a YoY change of 0.40%, and net profit of 1.12M, showing a YoY change of -71.78%. The Sankey diagram below clearly presents GDRX's revenue sources and cost distribution.

Key Indicators

Goodrx (GDRX) key financial stats and ratios, covering profitability, financial health, and leverage.
Goodrx (GDRX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Goodrx (GDRX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Goodrx (GDRX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Goodrx (GDRX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Goodrx (GDRX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield